Skip to main content

Gayathri R. Devi

Adjunct Professor in the Department of Surgery
Surgery, Surgical Sciences
Box 2606 Med Ctr, Durham, NC 27710
477 Med.Sci.Res.Bldg. (MSRB1), 2606 DUMC, Durham, NC 27710

Overview


Dr. Devi’s research interests include functional genomics, anti-cancer drug discovery and development, mechanisms of cancer cell signaling, tumor immunity and applications thereof for overcoming therapeutic resistance in cancer.

The lab has established prostate, inflammatory breast cancer and ovarian cellular and tumor models.

Current Appointments & Affiliations


Adjunct Professor in the Department of Surgery · 2026 - Present Surgery, Surgical Sciences, Surgery

In the News


Published November 22, 2023
Urban Environmental Factors Driving Breast Cancer Incidence
Published January 9, 2019
Cancer Cells Steer a Jagged Path
Published March 28, 2017
Study Shows How BPA May Affect Inflammatory Breast Cancer

View All News

Recent Publications


Multiscale Modeling Uncovers Macrophage Infiltration and TNF-α Signaling Networks for Targeting in Inflammatory Breast Cancer Tumor Emboli.

Journal Article bioRxiv · August 12, 2025 Inflammatory breast cancer (IBC) tumors are characterized by diffuse clusters of cells found in dermal tissue and lymphatic vessels, known as tumor emboli. Thus, IBC needs a novel treatment because it is the most aggressive breast cancer subtype. We hypoth ... Full text Link to item Cite

Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer.

Journal Article Breast Cancer (Dove Med Press) · 2025 BACKGROUND: Tumor-associated macrophages (TAMs) constitute an important part of the tumor microenvironment of breast cancer (BC), and they play an essential role in modulating tumor growth and invasion. However, the role of TAMs in neoadjuvant chemotherapy ... Full text Link to item Cite

Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer.

Journal Article NPJ Breast Cancer · July 29, 2024 Therapeutic resistance presents a significant hurdle in combating inflammatory breast cancer (IBC), adding to the complexity of its management. To investigate these mechanisms, we conducted a comprehensive analysis using transcriptomic and proteomic profil ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


University of Nebraska, College of Medicine · 1998 Ph.D.